Here are three things to know:
1. North America supplies the majority of spine biologics, with nearly 63 percent of the product market share. Europe is the second largest supplier with 28 percent market share.
2. North America has a consumption market share of nearly 61 percent, and Europe has a 21 percent consumption market share.
3. Medtronic, DePuy Synthes, Stryker, Nuvasive and Zimmer Biomet are leading market players.
More articles on biologics:
Vail-Summit Orthopaedics uses injectable treatments, biologics to expand care: 3 notes
Osiris Therapeutics appoints new CEO: 3 notes
SpinalCyte earns FDA clearance for fibroblast cell therapy: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
